Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Evidence for a role of phospholipid oxidation products in atherogenesis.

Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D.

Trends Cardiovasc Med. 2001 Apr-May;11(3-4):142-7. Review.

PMID:
11686004
2.

Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities.

Subbanagounder G, Watson AD, Berliner JA.

Free Radic Biol Med. 2000 Jun 15;28(12):1751-61. Review.

PMID:
10946217
3.
4.

Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.

Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2248-54.

5.

Oxidized phospholipids as modulators of inflammation in atherosclerosis.

Leitinger N.

Curr Opin Lipidol. 2003 Oct;14(5):421-30. Review.

PMID:
14501580
6.

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM.

J Lipid Res. 2004 Jun;45(6):993-1007. Epub 2004 Apr 1. Review.

7.

Oxidized phospholipids and isoprostanes in atherosclerosis.

Witztum JL, Berliner JA.

Curr Opin Lipidol. 1998 Oct;9(5):441-8. Review.

PMID:
9812198
8.

The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.

Spiteller G.

Mol Nutr Food Res. 2005 Nov;49(11):999-1013. Review.

PMID:
16270286
9.

Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.

Furnkranz A, Leitinger N.

Curr Pharm Des. 2004;10(8):915-21. Review.

PMID:
15032694
10.

Phospholipid mediators in the vessel wall: involvement in atherosclerosis.

Ninio E.

Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):123-31. Review.

PMID:
15716789
11.

Lipid oxidation in atherogenesis: an overview.

Jessup W, Kritharides L, Stocker R.

Biochem Soc Trans. 2004 Feb;32(Pt 1):134-8. Review.

PMID:
14748732
12.

Cholesterol oxidation products and fibrogenesis.

Leonarduzzi G, Sevanian A, Poli G.

Biofactors. 2001;15(2-4):117-9. Review.

PMID:
12016339
13.
14.

Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.

Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, Leitinger N.

Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):101-7.

15.

The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.

Leitinger N.

Subcell Biochem. 2008;49:325-50. doi: 10.1007/978-1-4020-8830-8_12. Review.

PMID:
18751917
16.

Vitamin E oxidation in human atherosclerotic lesions.

Terentis AC, Thomas SR, Burr JA, Liebler DC, Stocker R.

Circ Res. 2002 Feb 22;90(3):333-9.

17.

[Lipid peroxides and arteriosclerosis].

Lankin VZ, Tikhaze AK, Kotelevtseva NV.

Kardiologiia. 1976 Feb;16(2):23-30. Russian.

PMID:
966438
18.

Role of oxidative modifications in atherosclerosis.

Stocker R, Keaney JF Jr.

Physiol Rev. 2004 Oct;84(4):1381-478. Review.

19.

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Leitinger N.

Mol Nutr Food Res. 2005 Nov;49(11):1063-71. Review.

PMID:
16270279
20.

Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.

Yeh M, Cole AL, Choi J, Liu Y, Tulchinsky D, Qiao JH, Fishbein MC, Dooley AN, Hovnanian T, Mouilleseaux K, Vora DK, Yang WP, Gargalovic P, Kirchgessner T, Shyy JY, Berliner JA.

Circ Res. 2004 Oct 15;95(8):780-8. Epub 2004 Sep 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk